–
Aardvark Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY24 to FY25
millions USD
FY22:
FY23:
–
FY24:
−18.1
FY25:
−54.2
Change from FY22 to FY25
millions USD
FY22:
−1.00
FY23:
–
FY24:
−12.0
FY25:
−49.7
Change from FY22 to FY25
millions USD
FY22:
0.23
FY23:
0
FY24:
82.0
FY25:
89.2
(positive)
Change from FY22 to FY25
millions USD
FY22:
−10.5
FY23:
−5.82
FY24:
−18.2
FY25:
−54.3
All amounts in millions USD FY22, FY23: figures supplemented from Twelve Data because the SEC filings do not reach back this far.